Vanguard Fiduciary Trust
ARMP icon

Vanguard Fiduciary Trust’s Armata Pharmaceuticals ARMP Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Buy
79,495
+11,631
+17% +$107K ﹤0.01% 3262
2026
Q1 		$695K Buy
+67,864
New +$571K ﹤0.01% 3091

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Vanguard Fiduciary Trust's ARMP Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Armata Pharmaceuticals (ARMP) stake by 17% in Q2 2026, buying an estimated $107K and bringing the position to 79,495 shares worth $515K. The position accounts for ﹤0.01% of the portfolio, ranked #3262.

Vanguard Fiduciary Trust first reported a position in ARMP in Q1 2026 and has held it in 2 quarters since. The position peaked at $695K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Vanguard Fiduciary Trust held 79,495 shares of Armata Pharmaceuticals worth $515K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 11,631 Armata Pharmaceuticals shares in Q2 2026, an estimated $107K.
  • Armata Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3262 holding.
  • Vanguard Fiduciary Trust first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Armata Pharmaceuticals position peaked at $695K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.